Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2003;34:790-793
Published online before print February 20, 2003, doi: 10.1161/01.STR.0000057815.79289.EC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/3/790    most recent
01.STR.0000057815.79289.ECv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Worrall, B. B.
Right arrow Articles by DeGraba, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Worrall, B. B.
Right arrow Articles by DeGraba, T. J.
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Risk Factors
Right arrow Carotid Stenosis
Right arrow Genetics of Stroke
Right arrow Risk Factors for Stroke

(Stroke. 2003;34:790.)
© 2003 American Heart Association, Inc.


Research Reports

Interleukin-1 Receptor Antagonist Gene Polymorphisms in Carotid Atherosclerosis

Bradford B. Worrall, MD, MSc; Salman Azhar, MD; Paul A. Nyquist, MD; Robert H. Ackerman, MD; Theresa L. Hamm, RN Thomas J. DeGraba, MD

From the University of Virginia, Departments of Neurology and Health Evaluation Sciences (B.B.W.), Charlottesville, Va; Stroke Branch, National Institute of Neurological Disorders and Stroke, Bethesda, Md (B.B.W., S.A., P.A.N., T.L.H., T.J.D.); Massachusetts General Hospital, Departments of Neurology and Neuroradiology, Boston (R.H.A.); and National Naval Medical Center, Bethesda, Md (T.L.H., T.J.D.).

Correspondence to Dr Thomas J. DeGraba, National Naval Medical Center, Clinical Stroke Research Unit, Neurology Department, Building 9, 2nd Deck, 8901 Wisconsin Ave, Bethesda, MD 20889-5600. E-mail TJDeGraba{at}bethesda.med.navy.mil

Abstract

Background and Purpose— Inflammation plays an important role in the development of atherosclerosis. The gene for the counterinflammatory cytokine interleukin–1 receptor antagonist (IL-1ra) is polymorphic, and high frequencies of allele 2 have been found to be associated with other inflammatory diseases. This study examined the association of allele and carrier frequencies of the IL-1ra gene with the presence of carotid atherosclerosis and plaque symptomaticity.

Methods— A total of 328 subjects identified as having carotid atherosclerosis or no atherosclerosis (controls) participated. Blood was obtained for DNA determination.

Results— Frequency of allele 2 was significantly greater in patients with atherosclerosis compared with nonatherosclerotic subjects. No difference was seen between symptomatic and asymptomatic atherosclerosis patients. Noncarriage of allele 2 was associated with reduced likelihood of atherosclerosis (odds ratio [OR], 0.44; 95% CI, 0.27 to 0.71). The homozygous carrier state for allele 2 was associated with greater likelihood of atherosclerosis (unadjusted OR, 7.30; 95% CI, 2.31 to 22.94; adjusted OR, 13.78; 95% CI, 1.94 to 97.9). A gene-dose effect was detected.

Conclusions— These data suggest that allele 2 of the IL-1ra gene represents a susceptibility factor in the development of carotid atherosclerosis. Further investigation appears warranted.


Key Words: atherosclerosis • carotid artery diseases • cytokines • interleukin-1 receptor antagonist • polymorphism




This article has been cited by other articles:


Home page
StrokeHome page
B. B. Worrall, T. G. Brott, R. D. Brown Jr, W. M. Brown, S. S. Rich, S. Arepalli, F. Wavrant-De Vrieze, J. Duckworth, A. B. Singleton, J. Hardy, et al.
IL1RN VNTR Polymorphism in Ischemic Stroke: Analysis in 3 Populations
Stroke, April 1, 2007; 38(4): 1189 - 1196.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
G. M. Hadjigeorgiou, K. Paterakis, E. Dardiotis, M. Dardioti, K. Aggelakis, A. Tasiou, G. Xiromerisiou, A. Komnos, E. Zintzaras, N. Scarmeas, et al.
IL-1RN and IL-1B gene polymorphisms and cerebral hemorrhagic events after traumatic brain injury
Neurology, October 11, 2005; 65(7): 1077 - 1082.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Merhi-Soussi, B. R. Kwak, D. Magne, C. Chadjichristos, M. Berti, G. Pelli, R. W. James, F. Mach, and C. Gabay
Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice
Cardiovasc Res, June 1, 2005; 66(3): 583 - 593.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. J. DeGraba
Immunogenetic Susceptibility of Atherosclerotic Stroke: Implications on Current and Future Treatment of Vascular Inflammation
Stroke, November 1, 2004; 35(11_suppl_1): 2712 - 2719.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. A. Manolio, E. Boerwinkle, C. J. O'Donnell, and A. F. Wilson
Genetics of Ultrasonographic Carotid Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1567 - 1577.
[Abstract] [Full Text] [PDF]